The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 27, 2021

Filed:

Oct. 29, 2015
Applicants:

Massachusetts Eye and Ear Infirmary, Boston, MA (US);

President and Fellows of Harvard College, Cambridge, MA (US);

Inventors:

Zheng-Yi Chen, Somerville, MA (US);

David R. Liu, Cambridge, MA (US);

Margie Li, Cambridge, MA (US);

David B. Thompson, Cambridge, MA (US);

John Zuris, Cambridge, MA (US);

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/22 (2006.01); C12N 15/113 (2010.01); C12N 15/90 (2006.01); A61K 48/00 (2006.01); C12N 5/0793 (2010.01); A61K 38/00 (2006.01); C12N 15/88 (2006.01); C12N 15/87 (2006.01); A61K 38/10 (2006.01); C12N 9/00 (2006.01); A61K 47/64 (2017.01); A61K 47/69 (2017.01); A61K 9/127 (2006.01); C07J 7/00 (2006.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01); C07K 14/46 (2006.01); C07K 14/47 (2006.01); C07K 19/00 (2006.01); C12N 9/52 (2006.01); C12N 15/11 (2006.01);
U.S. Cl.
CPC ...
A61K 48/0008 (2013.01); A61K 9/1272 (2013.01); A61K 38/00 (2013.01); A61K 38/10 (2013.01); A61K 47/64 (2017.08); A61K 47/6911 (2017.08); A61K 48/0075 (2013.01); A61K 48/0083 (2013.01); C07J 7/009 (2013.01); C07K 7/06 (2013.01); C07K 7/08 (2013.01); C07K 14/463 (2013.01); C07K 14/47 (2013.01); C07K 19/00 (2013.01); C12N 5/062 (2013.01); C12N 9/00 (2013.01); C12N 9/22 (2013.01); C12N 9/52 (2013.01); C12N 15/11 (2013.01); C12N 15/113 (2013.01); C12N 15/87 (2013.01); C12N 15/88 (2013.01); C12N 15/907 (2013.01); C12Y 304/2207 (2013.01); C07K 2319/06 (2013.01); C07K 2319/21 (2013.01); C07K 2319/33 (2013.01); C07K 2319/60 (2013.01); C12N 2310/20 (2017.05); C12N 2310/3513 (2013.01); C12N 2510/00 (2013.01);
Abstract

Compositions are described for direct protein delivery into multiple cell types in the mammalian inner ear. The compositions are used to deliver protein(s) (such as gene editing factors) editing of genetic mutations associated with deafness or associated disorders thereof. The delivery of genome editing proteins for gene editing and correction of genetic mutations protect or restore hearing from genetic deafness. Methods of treatment include the intracellular delivery of these molecules to a specific therapeutic target.


Find Patent Forward Citations

Loading…